Post Marketing Surveillance Program of Idarucizumab Use in India.
Not yet recruiting
Phase of Trial: Phase IV
Latest Information Update: 19 Dec 2017
At a glance
- Drugs Idarucizumab (Primary)
- Indications Thromboembolism
- Focus Adverse reactions
- Sponsors Boehringer Ingelheim
- 12 Dec 2017 Planned initiation date changed from 4 Jan 2018 to 25 Feb 2018.
- 05 Dec 2017 New trial record